Grown Rogue International (GRUSF) Other Non-Current Liabilities (2009 - 2026)
Grown Rogue International (GRUSF) recorded quarterly Other Non-Current Liabilities of $9.2 million in Q1 2026, up 10.06% quarter-over-quarter from $8.4 million in Q4 2025, and up 1824.68% on a YoY basis from $479421.0 in Q1 2025.
Grown Rogue International (GRUSF) Other Non-Current Liabilities (2009 - 2026) Analysis & Trends
Grown Rogue International's Other Non-Current Liabilities history runs 14 years deep, the most recent figure standing at $9.2 million for Q1 2026.
- In Q1 2026, Other Non-Current Liabilities rose 1824.68% year-over-year to $9.2 million; the TTM figure through Mar 2026 stood at $9.2 million (up 1824.68% YoY), while the FY2025 annual figure was $8.4 million, down 32.95% from the prior year.
- Other Non-Current Liabilities was $9.2 million for Q1 2026 at Grown Rogue International, up from $8.4 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $657.6 billion in Q3 2025 to a low of $193195.5 in Q4 2024.
- Historically, Other Non-Current Liabilities has averaged $82.2 billion across 4 years, with a median of $4.9 million in 2023.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities slumped 96.01% in 2024, then soared 4239.59% in 2025.
- A 4-year view of Other Non-Current Liabilities shows it stood at $4.8 million in 2023, then plunged by 96.01% to $193195.5 in 2024, then jumped by 4239.59% to $8.4 million in 2025, then climbed by 10.06% to $9.2 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $9.2 million (Q1 2026), $8.4 million (Q4 2025), and $657.6 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Grown Rogue International | - | - | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.23 Mn |
| Dec 31, 2025 | 8.38 Mn |
| Sep 30, 2025 | 657.63 Bn |
| Jun 30, 2025 | 657,627.00 |
| Mar 31, 2025 | 479,421.00 |
| Dec 31, 2024 | 193,195.51 |
| Dec 31, 2023 | 4.85 Mn |
| Oct 31, 2023 | 4.87 Mn |
| May 31, 2018 | 583,997.90 |
| Feb 28, 2018 | 595,244.05 |
| Nov 30, 2017 | 597,802.38 |
| Aug 31, 2017 | 582,211.56 |
| May 31, 2017 | 2.19 Mn |
| Feb 28, 2017 | 2.23 Mn |
| Nov 30, 2016 | 2.22 Mn |
| Aug 31, 2016 | 2.26 Mn |
| May 31, 2016 | 3.40 Mn |
| Feb 29, 2016 | -3.42 Mn |
| Nov 30, 2015 | 3.14 Mn |
| Aug 31, 2015 | 627,607.02 |